Please login to the form below

Not currently logged in
Email:
Password:

Former Roche development head joins Asana advisory board

Dr Kapil Dhingra also brings experience from Lilly

Asana BioSciences Dr Kapil DhingraAsana BioSciences has appointed former head of Roche oncology clinical development Dr Kapil Dhingra to its oncology scientific advisory board.

Dr Dhingra served at Roche from 1999 to 2008, most recently as vice president, head of the Swiss pharma company's oncology disease biology leadership team and head of oncology clinical development.

Prior to that he worked at Lilly as a clinical research physician having previously served at the faculty of M.D. Anderson Cancer Center in Houston, Texas, where he pursued laboratory and clinical cancer research.

Dr Sandeep Gupta, founder, president and CEO of New Jersey-based Asana Biosciences, said: “We welcome Dr. Dhingra to our oncology scientific advisory board. His expertise, proven track record and strategic insights will be great assets to Asana.

I look forward to working closely with him and other SAB members in advancing our robust and differentiated oncology pipeline further into clinical development.”

The founder of KAPital Consulting, Dr Dhingra currently serves on the boards of Exosome Diagnostics as chairman of the board, Advanced Accelerator Applications, Five Prime and Autolus.

11th January 2016

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
nzyme

The nzyme group focuses on the three fundamentals that enable full patient access - Education, Access & Activation. Our specialist...

Latest intelligence

Value is in the eye of the customer. Co-creation is a bridge to value.
We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning. Our interviews reveal important insights about the tensions...
Partnering with Patients and Caregivers in Clinical Research
...
Practical advice for Early Scientific Advice (ESA) in HTA submissions
A step-by step guide on the benefits, processes, and key considerations involved in the Healthcare Technology Assessment (HTA) Early Scientific Advice (ESA) consultation as part of planning the holistic evidence...